US Stock MarketDetailed Quotes

PDS Biotechnology (PDSB)

Watchlist
  • 0.9801
  • +0.0354+3.75%
Trading Jan 16 13:09 ET
51.77MMarket Cap-1.21P/E (TTM)

PDS Biotechnology (PDSB) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-20.03%8.14M
-12.22%7.62M
-9.82%9.11M
-15.62%36.32M
-29.27%7.36M
-3.24%10.18M
-31.60%8.68M
7.17%10.1M
3.29%43.05M
-44.71%10.41M
Selling and administrative expenses
5.60%3.56M
-17.95%3.41M
-3.50%3.27M
-9.99%13.76M
-3.75%2.83M
-17.10%3.37M
-11.40%4.16M
-5.18%3.39M
24.84%15.28M
10.31%2.94M
-General and administrative expense
5.60%3.56M
-17.95%3.41M
-3.50%3.27M
-9.99%13.76M
-3.75%2.83M
-17.10%3.37M
-11.40%4.16M
-5.18%3.39M
24.84%15.28M
10.31%2.94M
Research and development costs
-32.74%4.58M
-6.95%4.21M
-13.02%5.83M
-18.72%22.57M
-39.33%4.53M
5.51%6.8M
-43.44%4.53M
14.72%6.7M
-5.67%27.76M
-53.79%7.47M
Operating profit
20.03%-8.14M
12.22%-7.62M
9.82%-9.11M
15.62%-36.32M
29.27%-7.36M
3.24%-10.18M
31.60%-8.68M
-7.17%-10.1M
-3.29%-43.05M
44.71%-10.41M
Net non-operating interest income expense
-58.64%-869.27K
-253.16%-1.81M
-9.33%-553.03K
-65.65%-2.16M
-20.46%-591.78K
-66.31%-547.96K
-109.51%-512.76K
-112.99%-505.85K
-241.69%-1.3M
-55.30%-491.25K
Non-operating interest income
-57.84%281.11K
-50.59%333.62K
-43.51%377.85K
-13.37%2.51M
-26.27%503.94K
-9.82%666.77K
-10.05%675.21K
-8.29%668.9K
210.42%2.9M
13.38%683.54K
Non-operating interest expense
-5.30%1.15M
80.52%2.14M
-20.76%930.88K
11.11%4.67M
-6.73%1.1M
13.64%1.21M
19.35%1.19M
21.50%1.17M
219.47%4.21M
27.81%1.17M
Other net income (expense)
Income before tax
16.01%-9.01M
-2.58%-9.43M
8.91%-9.66M
13.23%-38.48M
27.03%-7.95M
1.13%-10.73M
28.93%-9.2M
-9.77%-10.6M
-5.46%-44.35M
43.05%-10.9M
Income tax
0
0
-1.17M
38.18%-869.17K
0
0
38.18%-869.17K
0
-17.28%-1.41M
2
Net income
16.01%-9.01M
-13.28%-9.43M
19.94%-8.49M
12.42%-37.61M
27.03%-7.95M
1.13%-10.73M
27.80%-8.33M
-9.77%-10.6M
-5.11%-42.94M
43.05%-10.9M
Net income continuous Operations
16.01%-9.01M
-13.28%-9.43M
19.94%-8.49M
12.42%-37.61M
27.03%-7.95M
1.13%-10.73M
27.80%-8.33M
-9.77%-10.6M
-5.11%-42.94M
43.05%-10.9M
Minority interest income
Net income attributable to the parent company
16.01%-9.01M
-13.28%-9.43M
19.94%-8.49M
12.42%-37.61M
27.03%-7.95M
1.13%-10.73M
27.80%-8.33M
-9.77%-10.6M
-5.11%-42.94M
43.05%-10.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
16.01%-9.01M
-13.28%-9.43M
19.94%-8.49M
12.42%-37.61M
27.03%-7.95M
1.13%-10.73M
27.80%-8.33M
-9.77%-10.6M
-5.11%-42.94M
43.05%-10.9M
Basic earnings per share
34.48%-0.19
8.70%-0.21
30.00%-0.21
25.90%-1.03
40.00%-0.21
17.14%-0.29
37.84%-0.23
6.25%-0.3
2.80%-1.39
47.76%-0.35
Diluted earnings per share
34.48%-0.19
8.70%-0.21
30.00%-0.21
25.90%-1.03
40.00%-0.21
17.14%-0.29
37.84%-0.23
6.25%-0.3
2.80%-1.39
47.76%-0.35
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -20.03%8.14M-12.22%7.62M-9.82%9.11M-15.62%36.32M-29.27%7.36M-3.24%10.18M-31.60%8.68M7.17%10.1M3.29%43.05M-44.71%10.41M
Selling and administrative expenses 5.60%3.56M-17.95%3.41M-3.50%3.27M-9.99%13.76M-3.75%2.83M-17.10%3.37M-11.40%4.16M-5.18%3.39M24.84%15.28M10.31%2.94M
-General and administrative expense 5.60%3.56M-17.95%3.41M-3.50%3.27M-9.99%13.76M-3.75%2.83M-17.10%3.37M-11.40%4.16M-5.18%3.39M24.84%15.28M10.31%2.94M
Research and development costs -32.74%4.58M-6.95%4.21M-13.02%5.83M-18.72%22.57M-39.33%4.53M5.51%6.8M-43.44%4.53M14.72%6.7M-5.67%27.76M-53.79%7.47M
Operating profit 20.03%-8.14M12.22%-7.62M9.82%-9.11M15.62%-36.32M29.27%-7.36M3.24%-10.18M31.60%-8.68M-7.17%-10.1M-3.29%-43.05M44.71%-10.41M
Net non-operating interest income expense -58.64%-869.27K-253.16%-1.81M-9.33%-553.03K-65.65%-2.16M-20.46%-591.78K-66.31%-547.96K-109.51%-512.76K-112.99%-505.85K-241.69%-1.3M-55.30%-491.25K
Non-operating interest income -57.84%281.11K-50.59%333.62K-43.51%377.85K-13.37%2.51M-26.27%503.94K-9.82%666.77K-10.05%675.21K-8.29%668.9K210.42%2.9M13.38%683.54K
Non-operating interest expense -5.30%1.15M80.52%2.14M-20.76%930.88K11.11%4.67M-6.73%1.1M13.64%1.21M19.35%1.19M21.50%1.17M219.47%4.21M27.81%1.17M
Other net income (expense)
Income before tax 16.01%-9.01M-2.58%-9.43M8.91%-9.66M13.23%-38.48M27.03%-7.95M1.13%-10.73M28.93%-9.2M-9.77%-10.6M-5.46%-44.35M43.05%-10.9M
Income tax 00-1.17M38.18%-869.17K0038.18%-869.17K0-17.28%-1.41M2
Net income 16.01%-9.01M-13.28%-9.43M19.94%-8.49M12.42%-37.61M27.03%-7.95M1.13%-10.73M27.80%-8.33M-9.77%-10.6M-5.11%-42.94M43.05%-10.9M
Net income continuous Operations 16.01%-9.01M-13.28%-9.43M19.94%-8.49M12.42%-37.61M27.03%-7.95M1.13%-10.73M27.80%-8.33M-9.77%-10.6M-5.11%-42.94M43.05%-10.9M
Minority interest income
Net income attributable to the parent company 16.01%-9.01M-13.28%-9.43M19.94%-8.49M12.42%-37.61M27.03%-7.95M1.13%-10.73M27.80%-8.33M-9.77%-10.6M-5.11%-42.94M43.05%-10.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 16.01%-9.01M-13.28%-9.43M19.94%-8.49M12.42%-37.61M27.03%-7.95M1.13%-10.73M27.80%-8.33M-9.77%-10.6M-5.11%-42.94M43.05%-10.9M
Basic earnings per share 34.48%-0.198.70%-0.2130.00%-0.2125.90%-1.0340.00%-0.2117.14%-0.2937.84%-0.236.25%-0.32.80%-1.3947.76%-0.35
Diluted earnings per share 34.48%-0.198.70%-0.2130.00%-0.2125.90%-1.0340.00%-0.2117.14%-0.2937.84%-0.236.25%-0.32.80%-1.3947.76%-0.35
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More